NeuroPace Inc (NPCE)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch NPCE
See up to 3 months of NPCE. The 7-day demo opens the 1M and 3M ranges and puts NPCE on your watchlist.
Start 7-day demoLatest NPCE insider trades
- Martha Morrell - OfficerOpen-market sale$399K
- Martha Morrell - OfficerTax withholding / forfeiture$5K
Patrick F. Williams - Officer
About NeuroPace Inc (NPCE)
NeuroPace Inc is an SEC registrant, filing under CIK 0001528287, classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
NPCE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Tax withholding / forfeiture | 5 | 4,291 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NPCE insider transactions (Form 4)
4053 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Martha Morrell - Officer | Tax withholding / forfeiture | Common Stock | 335 footnote F1 | $13.97 footnote F1 | $5K | |
| ||||||
| Patrick F. Williams - Officer | Tax withholding / forfeiture | Common Stock | 1,162 footnote F1 | $14.28 footnote F1 | $17K | |
| ||||||
| Joel Becker - Officer | Tax withholding / forfeiture | Common Stock | 1,310 footnote F1 | $14.75 footnote F1 | $19K | |
| ||||||
| Joel Becker - Officer | Tax withholding / forfeiture | Common Stock | 1,126 footnote F1 | $14.13 footnote F1 | $16K | |
| ||||||
| Martha Morrell - Officer | Tax withholding / forfeiture | Common Stock | 358 footnote F1 | $14.13 footnote F1 | $5K | |
| ||||||
| Martha Morrell - Officer | Tax withholding / forfeiture | Common Stock | 335 footnote F1 | $16.22 footnote F1 | $5K | |
| ||||||
| Uri Geiger - Director | Grant or award | Common Stock | 789 footnote F1 | $15.63 | $12K | |
| ||||||
 Frank M. Fischer - Director | Grant or award | Common Stock | 1,467 footnote F1 | $15.63 | $23K | |
| ||||||
| Rakhi Kumar - Director | Grant or award | Common Stock | 989 footnote F1 | $15.63 | $15K | |
| ||||||
| R. Scott Huennekens - Director | Grant or award | Common Stock | 2,890 footnote F1 | $0.00 | - | |
| R. Scott Huennekens - Director | Grant or award | Stock Option (Right to Buy) | 5,368 | $0.00 | - | |
| ||||||
| Frank M. Fischer - Director | Grant or award | Common Stock | 2,890 footnote F1 | $0.00 | - | |
| Frank M. Fischer - Director | Grant or award | Stock Option (Right to Buy) | 5,368 | $0.00 | - | |
| ||||||
| Uri Geiger - Director | Grant or award | Common Stock | 2,890 footnote F1 | $0.00 | - | |
| Uri Geiger - Director | Grant or award | Stock Option (Right to Buy) | 5,368 | $0.00 | - | |
| ||||||
| Rakhi Kumar - Director | Grant or award | Common Stock | 2,890 footnote F1 | $0.00 | - | |
| Rakhi Kumar - Director | Grant or award | Stock Option (Right to Buy) | 5,368 | $0.00 | - | |
| ||||||
| Renee Ryan - Director | Grant or award | Common Stock | 2,890 footnote F1 | $0.00 | - | |
| Renee Ryan - Director | Grant or award | Stock Option (Right to Buy) | 5,368 | $0.00 | - | |
| ||||||
 Lisa Andrade - Director | Grant or award | Common Stock | 2,890 footnote F1 | $0.00 | - | |
| Lisa Andrade - Director | Grant or award | Stock Option (Right to Buy) | 5,368 | $0.00 | - | |
| ||||||
| Joel Becker - Officer | Tax withholding / forfeiture | Common Stock | 1,255 footnote F1 | $15.88 footnote F1 | $20K | |
| ||||||
| Joel Becker - Officer | Tax withholding / forfeiture | Common Stock | 1,126 footnote F1 | $17.06 footnote F1 | $19K | |
| ||||||
| Martha Morrell - Officer | Tax withholding / forfeiture | Common Stock | 358 footnote F1 | $17.06 footnote F1 | $6K | |
| ||||||
| Patrick F. Williams - Officer | Grant or award | Common Stock | 16,820 footnote F1 | $0.00 | - | |
| Patrick F. Williams - Officer | Grant or award | Stock Option (Right to Buy) | 44,800 | $0.00 | - | |
| ||||||
| Martha Morrell - Officer | Grant or award | Common Stock | 5,460 footnote F1 | $0.00 | - | |
| Martha Morrell - Officer | Grant or award | Stock Option (Right to Buy) | 14,550 | $0.00 | - | |
| ||||||
| Joel Becker - Officer | Grant or award | Common Stock | 45,880 footnote F1 | $0.00 | - | |
| Joel Becker - Officer | Grant or award | Stock Option (Right to Buy) | 122,190 | $0.00 | - | |
| ||||||
| Martha Morrell - Officer | Tax withholding / forfeiture | Common Stock | 1,341 footnote F1 | $13.27 footnote F1 | $18K | |
| ||||||
| Uri Geiger - Director | Grant or award | Common Stock | 913 footnote F1 | $13.00 | $12K | |
| ||||||
 Joseph Lacob - Director | Grant or award | Common Stock | 865 footnote F1 | $13.00 | $11K | |
| ||||||
| Rakhi Kumar - Director | Grant or award | Common Stock | 1,153 footnote F1 | $13.00 | $15K | |
| ||||||
| Frank M. Fischer - Director | Grant or award | Common Stock | 1,826 footnote F1 | $13.00 | $24K | |
| ||||||
| Martha Morrell - Officer | Open-market sale | Common Stock | 25,000 | $15.97 footnote F2 | $399K | |
| Martha Morrell - Officer | Tax withholding / forfeiture | Common Stock | 1,340 footnote F3 | $13.83 | $19K | |
| ||||||
| Joel Becker - Officer | Tax withholding / forfeiture | Common Stock | 5,023 footnote F1 | $13.83 footnote F1 | $69K | |
| ||||||
| Joel Becker - Officer | Tax withholding / forfeiture | Common Stock | 1,126 footnote F1 | $14.58 footnote F1 | $16K | |
| ||||||
| Martha Morrell - Officer | Tax withholding / forfeiture | Common Stock | 358 footnote F1 | $14.58 footnote F1 | $5K | |
| ||||||
Item 2.02, 9.01
Item 7.01, 9.01
Item 5.07
Item 2.02, 9.01
NPCE insider trading FAQ
What is the latest insider trade for NPCE?
NeuroPace Inc (NPCE) had 5 insider filings in the last 90 days, with the most recent on 2026-09-25. The full record for NPCE runs to 53 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NPCE stock?
No insider purchases of NPCE were filed in the last 90 days.
How many insiders are selling NPCE stock?
No insider sales of NPCE were filed in the last 90 days. 32 sales are on record for this company.
Where can I see NPCE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NPCE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Martha Morrell view on EDGAR
- - Patrick F. Williams view on EDGAR
- - Joel Becker view on EDGAR
- - Joel Becker view on EDGAR
- - Martha Morrell view on EDGAR
- - Martha Morrell view on EDGAR
- - Uri Geiger view on EDGAR
- - Frank M. Fischer view on EDGAR
- - Rakhi Kumar view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where NPCE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NPCE with a 7-day demo
- NPCE on your watchlist
- Every NPCE Form 4 filing on record
- Up to 3 months of NPCE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
